Vogels, Chantal B. F.
Hill, Verity
Breban, Mallery I.
Chaguza, Chrispin
Paul, Lauren M.
Sodeinde, Afeez
Taylor-Salmon, Emma
Ott, Isabel M.
Petrone, Mary E.
Dijk, Dennis
Jonges, Marcel
Welkers, Matthijs R. A.
Locksmith, Timothy
Dong, Yibo
Tarigopula, Namratha
Tekin, Omer
Schmedes, Sarah
Bunch, Sylvia
Cano, Natalia
Jaber, Rayah
Panzera, Charles
Stryker, Ian
Vergara, Julieta
Zimler, Rebecca
Kopp, Edgar
Heberlein, Lea
Herzog, Kaylee S.
Fauver, Joseph R.
Morrison, Andrea M.
Michael, Scott F.
Grubaugh, Nathan D.
Funding for this research was provided by:
National Center for Advancing Translational Sciences (UL1 TR001863)
National Institutes of Health (T32AI055403)
National Science Foundation Graduate Research Fellowship Program (DGE-2139841)
National Institute of General Medical Sciences (R21GM142011)
National Institute of Allergy and Infectious Diseases (DP2AI176740)
Article History
Received: 16 November 2023
Accepted: 25 April 2024
First Online: 1 May 2024
Declarations
:
: The Florida Department of Health shared de-identified remnant clinical specimens that tested positive for dengue virus for sequencing at the Yale School of Public Health. The Institutional Review Boards (IRB) from the Yale University Human Research Protection Program, Florida Gulf Coast University, and Florida Department of Health determined that pathogen genomic sequencing of de-identified remnant diagnostic samples as conducted in this study is not research involving human subjects (Yale IRB Protocol ID: 2000033281 and 2000028599).
: Not applicable.
: The authors declare no competing interests.